Cargando…
Synthesis, characterization, and mechanistic studies of a gold nanoparticle–amphotericin B covalent conjugate with enhanced antileishmanial efficacy and reduced cytotoxicity
BACKGROUND: Amphotericin B (AmB) as a liposomal formulation of AmBisome is the first line of treatment for the disease, visceral leishmaniasis, caused by the parasite Leishmania donovani. However, nephrotoxicity is very common due to poor water solubility and aggregation of AmB. This study aimed to...
Autores principales: | Kumar, Prakash, Shivam, Pushkar, Mandal, Saptarshi, Prasanna, Pragya, Kumar, Saurabh, Prasad, Surendra Rajit, Kumar, Ashish, Das, Prolay, Ali, Vahab, Singh, Shubhankar Kumar, Mandal, Debabrata |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6709383/ https://www.ncbi.nlm.nih.gov/pubmed/31686803 http://dx.doi.org/10.2147/IJN.S196421 |
Ejemplares similares
-
Mechanistic insight into the role of mevalonate kinase by a natural fatty acid-mediated killing of Leishmania donovani
por: Prasad, Surendra Rajit, et al.
Publicado: (2022) -
Mahanine exerts in vitro and in vivo antileishmanial activity by modulation of redox homeostasis
por: Roy, Saptarshi, et al.
Publicado: (2017) -
N-(2-hydroxypropyl)methacrylamide–amphotericin B (HPMA–AmB) copolymer conjugates as antileishmanial agents
por: Nicoletti, Salvatore, et al.
Publicado: (2009) -
Antileishmanial Activity of Amphotericin B-loaded-PLGA Nanoparticles: An Overview
por: Palma, Ernesto, et al.
Publicado: (2018) -
Evaluation of Safety and Antileishmanial Efficacy of Amine Functionalized Carbon-Based Composite Nanoparticle Appended With Amphotericin B: An in vitro and Preclinical Study
por: Gedda, Mallikarjuna Rao, et al.
Publicado: (2020)